Beijing has since 2015 stressed intellectual property education as part of a national strategy to become a technology leader, according to a report broadcast on
Beijing has since 2015 stressed intellectual property education as part of a national strategy to become a technology leader, according to a report broadcast on
A provocative new book by an award-winning author, entrepreneur and politician disputes the contribution of tens of thousands of individual inventors to major innovations, like
While bigtech revenue and share prices are soaring amidst the COVID-19 pandemic, and the market value of the top players dwarfs other companies, payouts in
Guest Column by Dr. Roya Ghafele With a rapidly growing market that offers both attractive returns on investment and the genuine ability to transform the
Approximately 54 scientists have resigned or been fired as a result of an ongoing investigation by the National Institutes of Health into the failure of NIH
The recently announced acquisition of Finjan Holdings, Inc. (NASDAQ: FNJN), a cybersecurity and patent licensing firm, by Fortress Investment Group, a division of SoftBank, is being
A Chinese court ordered a Shenzhen company to pay three million yuan ($430,000 USD) each in two lawsuits filed by MGM Holdings for trademark infringement
Intellectual property is the domain of every student, not just those studying law. That’s the conclusion reached by Phil Hearne, Director of Education for the
This week IPwe, the company headed by former patent litigation king Erich Spangenberg, acquired ClearAccess IP, a venture-backed, Palo Alto-based IP analytics company associated through
A newly released video featuring conversations with leading intellectual property practitioners, professionals and creators stresses the need to assure the role of IP rights is
A recent United States Supreme Court ruling involving a video about diving for sunken treasure that depicted the recovery of artifacts from Blackbeard’s 18th century
Johnson & Johnson, the pharmaceutical giant, said yesterday it is five months away from starting human trials on a COVID-19 vaccine that would be offered